
Adiponectin and Risk of Coronary Heart Disease in Older Men and Women
Context: Despite established insulin-sensitizing and antiatherogenic preclinical effects, epidemiological investigations of adiponectin have yielded conflicting findings, and its relationship with coronary heart disease (CHD) remains uncertain.
Objective: Our objective was to investigate the relationship between adiponectin and CHD in older adults.
Design, Setting, and Participants: This was a case-control study (n = 1386) nested within the population-based Cardiovascular Health Study from 1992 to 2001. Controls were frequency-matched to cases by age, sex, race, subclinical cardiovascular disease, and center.
Main Outcome Measures: Incident CHD was defined as angina pectoris, percutaneous or surgical revascularization, nonfatal myocardial infarction (MI), or CHD death. A more restrictive CHD endpoint was limited to nonfatal MI and CHD death.
Results: Adiponectin exhibited significant negative correlations with baseline adiposity, insulin resistance, dyslipidemia, inflammatory markers, and leptin. After controlling for matching factors, adjustment for waist to hip ratio, hypertension, smoking, alcohol, low-density lipoprotein cholesterol, creatinine, and leptin revealed a modestly increased risk of incident CHD with adiponectin concentrations at the upper end [odds ratio = 1.37 (quintile 5 vs. 1 to 4), 95% confidence interval 1.02 to 1.84]. This association was stronger when the outcome was limited to nonfatal MI and fatal CHD (odds ratio = 1.69, 95% confidence interval 1.23 to 2.32). The findings were not influenced by additional adjustment for weight change, health status, or cystatin C, nor were they abolished by adjustment for potential mediators.
Conclusions: This study shows an association between adiponectin and increased risk of first-ever CHD in older adults. Further research is needed to elucidate the basis for the concurrent beneficial and detrimental aspects of this relationship, and under what circumstances one or the other may predominate.
- · 青霉胺和前列腺素的作用
- · 決定心肌微循環(huán)灌注量的主要因素是什么?
- · 決定心肌微循環(huán)灌注量的主要因素
- · 臨床執(zhí)業(yè)醫(yī)師輔導(dǎo)精華:心絞痛
- · 心絞痛(angina pectoris)(3)
- · 心絞痛(angina pectoris)(1)
- · Adiponectin and Risk of Coronary Heart Disease in Older Men and Women
- · 氯吡格雷抵抗研究進展
- · 超濾技術(shù)及其在體外循環(huán)中的應(yīng)用
- · 臨床執(zhí)業(yè)醫(yī)師《內(nèi)科學(xué)》輔導(dǎo):變異性心絞痛Ⅰ